Tapewire

Nasdaq · USD

CPIX

CUMBERLAND PHARMACEUTICALS INC

Export transactions ↓
Tapewire entity
6757
SEC CIK
0001087294
Parsed reports
362

Last 12 months

Inside the activity.

0 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 22, 2022 Filed Sep 30, 2022 21:11 UTC PurchaseCommon Stock 110 $2.51 $276.10
Disclosure

SEC source: 0001209191-22-051665 · doc4.xml · nonDerivative · entry 5

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,450

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 19, 2022 Filed Sep 30, 2022 21:17 UTC PurchaseCommon Stock 20 $2.35 $47.00
Disclosure

SEC source: 0001209191-22-051671 · doc4.xml · nonDerivative · entry 4

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,762

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 19, 2022 Filed Sep 30, 2022 21:15 UTC
Jones JamesDirector
PurchaseCommon Stock 32 $2.35 $75.20
Disclosure

SEC source: 0001209191-22-051669 · doc4.xml · nonDerivative · entry 4

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,383

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 19, 2022 Filed Sep 30, 2022 21:13 UTC PurchaseCommon Stock 65 $2.35 $152.75
Disclosure

SEC source: 0001209191-22-051667 · doc4.xml · nonDerivative · entry 4

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,151

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 19, 2022 Filed Sep 30, 2022 21:11 UTC PurchaseCommon Stock 110 $2.35 $258.50
Disclosure

SEC source: 0001209191-22-051665 · doc4.xml · nonDerivative · entry 4

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,340

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 18, 2022 Filed Sep 30, 2022 21:17 UTC PurchaseCommon Stock 20 $2.23 $44.60
Disclosure

SEC source: 0001209191-22-051671 · doc4.xml · nonDerivative · entry 3

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,742

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 18, 2022 Filed Sep 30, 2022 21:15 UTC
Jones JamesDirector
PurchaseCommon Stock 32 $2.23 $71.36
Disclosure

SEC source: 0001209191-22-051669 · doc4.xml · nonDerivative · entry 3

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,351

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 18, 2022 Filed Sep 30, 2022 21:13 UTC PurchaseCommon Stock 65 $2.23 $144.95
Disclosure

SEC source: 0001209191-22-051667 · doc4.xml · nonDerivative · entry 3

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,086

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 18, 2022 Filed Sep 30, 2022 21:11 UTC PurchaseCommon Stock 110 $2.23 $245.30
Disclosure

SEC source: 0001209191-22-051665 · doc4.xml · nonDerivative · entry 3

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,230

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 17, 2022 Filed Sep 30, 2022 21:17 UTC PurchaseCommon Stock 20 $2.31 $46.20
Disclosure

SEC source: 0001209191-22-051671 · doc4.xml · nonDerivative · entry 2

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,722

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 17, 2022 Filed Sep 30, 2022 21:15 UTC
Jones JamesDirector
PurchaseCommon Stock 32 $2.31 $73.92
Disclosure

SEC source: 0001209191-22-051669 · doc4.xml · nonDerivative · entry 2

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,319

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 17, 2022 Filed Sep 30, 2022 21:13 UTC PurchaseCommon Stock 65 $2.31 $150.15
Disclosure

SEC source: 0001209191-22-051667 · doc4.xml · nonDerivative · entry 2

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 51,021

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 17, 2022 Filed Sep 30, 2022 21:11 UTC PurchaseCommon Stock 110 $2.31 $254.10
Disclosure

SEC source: 0001209191-22-051665 · doc4.xml · nonDerivative · entry 2

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,120

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 16, 2022 Filed Sep 30, 2022 21:17 UTC PurchaseCommon Stock 20 $2.35 $47.00
Disclosure

SEC source: 0001209191-22-051671 · doc4.xml · nonDerivative · entry 1

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,702

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 16, 2022 Filed Sep 30, 2022 21:15 UTC
Jones JamesDirector
PurchaseCommon Stock 32 $2.35 $75.20
Disclosure

SEC source: 0001209191-22-051669 · doc4.xml · nonDerivative · entry 1

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,287

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 16, 2022 Filed Sep 30, 2022 21:13 UTC PurchaseCommon Stock 65 $2.35 $152.75
Disclosure

SEC source: 0001209191-22-051667 · doc4.xml · nonDerivative · entry 1

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,956

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 16, 2022 Filed Sep 30, 2022 21:11 UTC PurchaseCommon Stock 110 $2.35 $258.50
Disclosure

SEC source: 0001209191-22-051665 · doc4.xml · nonDerivative · entry 1

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 194,010

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 15, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 20 $2.45 $49.00
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 28

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,682

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 15, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 32 $2.45 $78.40
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 28

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,255

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 15, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 65 $2.45 $159.25
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 28

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,891

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 15, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 110 $2.45 $269.50
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 28

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,900

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 12, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 26 $2.52 $65.52
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 27

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,662

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 12, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.52 $100.80
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 27

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,223

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 12, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 82 $2.52 $206.64
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 27

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,826

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 12, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 138 $2.52 $347.76
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 27

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,790

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 11, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 26 $2.46 $63.96
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 26

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,636

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 11, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.46 $98.40
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 26

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,183

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 11, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 82 $2.46 $201.72
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 26

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,744

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 11, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 138 $2.46 $339.48
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 26

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,652

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 10, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 26 $2.19 $56.94
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 25

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,610

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 10, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.19 $87.60
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 25

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,143

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 10, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 82 $2.19 $179.58
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 25

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,662

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 10, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 138 $2.19 $302.22
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 25

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,514

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 09, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 26 $2.19 $56.94
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 24

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,584

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 09, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.19 $87.60
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 24

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,103

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 09, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 82 $2.19 $179.58
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 24

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,580

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 09, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 138 $2.19 $302.22
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 24

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,376

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 08, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 26 $2.19 $56.94
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 23

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,558

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 08, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 40 $2.19 $87.60
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 23

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,063

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 08, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 82 $2.19 $179.58
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 23

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,498

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 08, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 138 $2.19 $302.22
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 23

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,238

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 05, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.12 $50.88
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 22

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,532

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 05, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.12 $78.44
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 22

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,023

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 05, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.12 $156.88
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 22

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,416

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 05, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.12 $262.88
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 22

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 193,100

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 04, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 24 $2.17 $52.08
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 21

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,508

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 04, 2022 Filed Aug 19, 2022 21:31 UTC
Jones JamesDirector
PurchaseCommon Stock 37 $2.17 $80.29
Disclosure

SEC source: 0001209191-22-046898 · doc4.xml · nonDerivative · entry 21

Jones James · CIK 0001490829 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,986

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 04, 2022 Filed Aug 19, 2022 21:30 UTC PurchaseCommon Stock 74 $2.17 $160.58
Disclosure

SEC source: 0001209191-22-046896 · doc4.xml · nonDerivative · entry 21

Galante Joseph C · CIK 0001632384 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,342

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 04, 2022 Filed Aug 19, 2022 21:28 UTC PurchaseCommon Stock 124 $2.17 $269.08
Disclosure

SEC source: 0001209191-22-046894 · doc4.xml · nonDerivative · entry 21

Krogulski Kenneth · CIK 0001695580 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 192,976

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document
August 03, 2022 Filed Aug 19, 2022 21:32 UTC PurchaseCommon Stock 12 $2.45 $29.40
Disclosure

SEC source: 0001209191-22-046900 · doc4.xml · nonDerivative · entry 20

Young Caroline · CIK 0001684087 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,484

F1 · shares: The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.